Effect of Co-Trimoxazole vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Co-Trimoxazole (Trimethoprim–Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial
JAMA 2020 Dec 08;324(22)2282-2291, AM Wilson, AB Clark, T Cahn, ER Chilvers, W Fraser, M Hammond, DM Livermore, TM Maher, H Parfrey, AM Swart, S Stirling, DR Thickett, M WhyteFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.